Based on the Spearman correlation analysis, the serum sclerostin levels were positively associated with diabetes (p = 0.004), but negatively associated with dialysis duration (p = 0.036), diastolic BP (p = 0.002), and iPTH (p = 0.037) in the HD group. Here, SOST is linked to diabetes mellitus.